Generic Dimenhydrinate Injection USP for Motion Sickness [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2004-08-26 18:29 (6739 d 05:05 ago) – Posting: # 8
Views: 13,194

The FDA approved on 24 June 2004 a new generic of dimenhydrinate (dimenhydrinate injection USP, made by American Pharmaceutical Partners, Inc.), an antiemetic indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It is the generic equivalent of Dramamine (made by Pfizer) and will be available in 50 mg/mL, 1 mL vials.

Manufacturing of dimenhydrinate injection had been discontinued since 2000 for reasons other than safety or efficacy.

Medscape members may follow this link:
http://www.medscape.com/viewarticle/482387

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
20 visitors (0 registered, 20 guests [including 10 identified bots]).
Forum time: 22:34 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5